- Lessons Learned Lessons Learned: How to balance residency and a budding career in venture capital
- The Readout LOUD LISTEN: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts
- Biotech Offering free DNA sequencing, Nebula Genomics opens for business. But there’s an itsy-bitsy catch
- Biotech Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more
- In the Lab With brain implants, scientists hope to translate paralyzed patients’ thoughts into speech
- Politics A newcomer rises to the defense of pharma — and tries to salvage its bruised reputation
- Biotech Offering free DNA sequencing, Nebula Genomics opens for business. But there’s an itsy-bitsy catch
- Business As social media ‘influencers,’ patients are getting a voice. And pharma is ready to pay up
-
- First Opinion U.S. hospitals ignore improving elder care. That’s a mistake
- Health As new therapies arrive, pressure builds on the health care system to figure out how to pay for them
